Abbott has unveiled Libre Assist, a feature in its Libre app that’s designed to help people living with diabetes in the U.S. better understand how the foods they eat affect their glucose levels.

Traditional food logging apps only provide feedback after a meal is logged—Libre Assist helps people make informed mealtime decisions before they eat. Abbott plans to launch the new technology during CES 2026.

Libre Assist leverages generative artificial intelligence (AI) to predict how a food choice might affects an individual’s glucose levels. It then provides actionable, personalized meal guidance to support decisions in the moment. After the meal, it uses data from the company’s Libre continuous glucose monitoring (CGM) sensors to confirm the actual impact.

“The Libre Assist feature is a gamechanger for me,” said Shirley Bovshow, who lives with Type 2 diabetes and is one of the first to try Abbott’s new feature. “Traditional food logging apps left me guessing. With Libre Assist I can see how a meal might affect my glucose before I eat—especially helpful when dining out or trying new foods. It gives me tips to reduce the glucose impact and my Libre 3 Plus sensor confirms the outcome afterward. The Libre app has become a go-to tool for me.”

Before eating, users take a photo or enter a text description of their food. The algorithm identifies the ingredients and predicts the meal’s potential glucose impact by showing a color-coded rating: green for minor, yellow for moderate, and orange for major. It also offers practical meal tips to lower potential glucose impact—for example, choosing pain Greek yogurt instead of flavored or eating leafy greens and proteins before starches.

After a meal, Libre Assist shows personal glucose data from the Libre CGM system sensor to demonstrate how the meal affected their glucose. The personalized feedback, according to Abbott, helps people understand their body’s unique response to different food items so they can make informed decisions in the future.

“People living with diabetes need more than apps that just log food and fall short of helping them with meal decisions,” said Marc Taub, vice president of technical operations for Abbott’s diabetes care business. “That’s why Abbott built Libre Assist—a free, and advanced predictive tool that delivers personalized meal guidance and works with our leading Libre technology to deliver real-time glucose insights. For the first time, people have smart, in-the-moment support right at their fingertips to make a confident choice every time they eat.”

Last month, the company revealed that its Lingo over-the-counter (OTC) CGM and app became available for Android devices.